Suppr超能文献

[I]I-EOE-TPZ和[I]I-EOE-TPZMO的研发:基于替拉扎明(TPZ)的新型放射性碘化药物,用于缺氧的诊疗管理。

Development of [I]I-EOE-TPZ and [I]I-EOE-TPZMO: Novel Tirapazamine (TPZ)-Based Radioiodinated Pharmaceuticals for Application in Theranostic Management of Hypoxia.

作者信息

Elsaidi Hassan, Ahmadi Fatemeh, Wiebe Leonard I, Kumar Piyush

机构信息

Department of Oncology, Cross Cancer Institute, Faculty of Medicine and Dentistry, University of Alberta, 11560 University Avenue, Edmonton, AB T6G 1Z2, Canada.

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Alexandria, El Sultan Hussein St. Azarita, Alexandria 21521, Egypt.

出版信息

Pharmaceuticals (Basel). 2019 Jan 1;12(1):3. doi: 10.3390/ph12010003.

Abstract

: Benzotriazine-1,4-dioxides (BTDOs) such as tirapazamine (TPZ) and its derivatives act as radiosensitizers of hypoxic tissues. The benzotriazine-1-monoxide (BTMO) metabolite (SR 4317, TPZMO) of TPZ also has radiosensitizing properties, and via unknown mechanisms, is a potent enhancer of the radiosensitizing effects of TPZ. Unlike their 2-nitroimidazole radiosensitizer counterparts, radiolabeled benzotriazine oxides have not been used as radiopharmaceuticals for diagnostic imaging or molecular radiotherapy (MRT) of hypoxia. The radioiodination chemistry for preparing model radioiodinated BTDOs and BTMOs is now reported. : Radioiodinated 3-(2-iodoethoxyethyl)-amino-1,2,4-benzotriazine-1,4-dioxide (I-EOE-TPZ), a novel bioisosteric analogue of TPZ, and 3-(2-iodoethoxyethyl)-amino-1,2,4-benzotriazine-1-oxide (I-EOE-TPZMO), its monoxide analogue, are candidates for in vivo and in vitro investigations of biochemical mechanisms in pathologies that develop hypoxic microenvironments. In theory, both radiotracers can be prepared from the same precursors. : Radioiodination procedures were based on classical nucleophilic [I]iodide substitution on Tos-EOE-TPZ (P1) and by [I]iodide exchange on I-EOE-TPZ (P2). Reaction parameters, including temperature, reaction time, solvent and the influence of pivalic acid on products' formation and the corresponding radiochemical yields (RCY) were investigated. : The [I]iodide labeling reactions invariably led to the synthesis of both products, but with careful manipulation of conditions the preferred product could be recovered as the major product. Radioiodide exchange on P2 in ACN at 80 ± 5 °C for 30 min afforded the highest RCY, 89%, of [I]I-EOE-TPZ, which upon solid phase purification on an alumina cartridge gave 60% yield of the product with over 97% of radiochemical purity. Similarly, radioiodide exchange on P2 in ACN at 50 ± 5 °C for 30 min with pivalic acid afforded the highest yield, 92%, of [I]I-EOE-TPZMO exclusively with no trace of [I]I-EOE-TPZ. In both cases, extended reaction times and/or elevated temperatures resulted in the formation of at least two additional radioactive reaction products. : Radioiodination of P1 and P2 with [I]iodide leads to the facile formation of [I]I-EOE-TPZMO. At 80 °C and short reaction times, the facile reduction of the N-4-oxide moiety was minimized to afford acceptable radiochemical yields of [I]I-EOE-TPZ from either precursor. Regeneration of [I]I-EOE-TPZ from [I]I-EOE-TPZMO is impractical after reaction work-up.

摘要

苯并三嗪 - 1,4 - 二氧化物(BTDOs),如替拉扎明(TPZ)及其衍生物,可作为缺氧组织的放射增敏剂。TPZ的苯并三嗪 - 1 - 氧化物(BTMO)代谢物(SR 4317,TPZMO)也具有放射增敏特性,并且通过未知机制,是TPZ放射增敏作用的强效增强剂。与它们的2 - 硝基咪唑类放射增敏剂不同,放射性标记的苯并三嗪氧化物尚未用作缺氧的诊断成像或分子放射治疗(MRT)的放射性药物。现将制备模型放射性碘标记的BTDOs和BTMOs的放射性碘化化学方法报道如下。:放射性碘标记的3 - (2 - 碘乙氧基乙基) - 氨基 - 1,2,4 - 苯并三嗪 - 1,4 - 二氧化物(I - EOE - TPZ),一种TPZ的新型生物电子等排体类似物,及其一氧化物类似物3 - (2 - 碘乙氧基乙基) - 氨基 - 1,2,4 - 苯并三嗪 - 1 - 氧化物(I - EOE - TPZMO),是用于对形成缺氧微环境的病理学中的生化机制进行体内和体外研究的候选物。理论上,两种放射性示踪剂都可以由相同的前体制备。:放射性碘化程序基于对Tos - EOE - TPZ(P1)进行经典的亲核[I]碘化物取代以及对I - EOE - TPZ(P2)进行[I]碘化物交换。研究了反应参数,包括温度、反应时间、溶剂以及新戊酸对产物形成和相应放射化学产率(RCY)的影响。:[I]碘化物标记反应总是会生成两种产物,但通过仔细控制条件,可以将优选产物作为主要产物回收。在80±5°C下于乙腈中对P2进行30分钟的碘化物交换,得到[I]I - EOE - TPZ的最高RCY,即89%,该产物在氧化铝柱上进行固相纯化后,产物产率为60%,放射化学纯度超过97%。同样,在50±5°C下于乙腈中对P2进行30分钟的碘化物交换并加入新戊酸,得到[I]I - EOE - TPZMO的最高产率,即92%,且完全没有[I]I - EOE - TPZ的痕迹。在这两种情况下,延长反应时间和/或升高温度会导致至少另外两种放射性反应产物的形成。:用[I]碘化物对P1和P2进行放射性碘化会导致[I]I - EOE - TPZMO的轻松形成。在80°C和短反应时间下,N - 4 - 氧化物部分的轻松还原被最小化,从而从前体中得到可接受的[I]I - EOE - TPZ放射化学产率。反应后处理后,从[I]I - EOE - TPZMO再生[I]I - EOE - TPZ是不切实际的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e18/6469288/a2b1ee79a1f4/pharmaceuticals-12-00003-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验